Objective To compare misoprostol with standard oxytocic regimens in the prevention of
postpartum haemorrhage. Design Randomised controlled trial. Setting Obstetric unit in a …

Introduction: Hemorrhage of the third stage of labor is a major cause of maternal mortality in
the world. Oxytocin is the first and standard treatment for postpartum hemorrhage however …

Background While inferior to oxytocin injection in both efficacy and safety, orally
administered misoprostol has been included in the World Health Organization Model List of …

Aims: This study aimed at comparing the efficacy of oral misoprostol 600 mcg with
intramuscular oxytocin 10 IU in the active management of third stage of labour. Methods …

Introduction: Uterotonic drugs are recommended for the prevention and treatment of
postpartum hemorrhage (PPH), and oxytocin is considered the gold standard for both …

Postpartum haemorrhage (PPH) causes preventable maternal deaths, mainly in low-income
countries. Misoprostol has powerful uterotonic effects and, because it is well absorbed orally …

Objective To compare the effects of misoprostol versus ergometrine‐oxytocin for postpartum
haemorrhage (PPH) prevention, and provide important evidence to choose optimal agents …

Background: Postpartum Haemorrhage (PPH) still remains a major cause of maternal
mortality despite adequate knowledge of its causes and treatment. Oxytocin administration is …

Background: To evaluate the effect of adjunctive misoprostol in preventing postpartum
haemorrhage (PPH) by selective administration above threshold bleeding in order to reduce …

Abstract Introduction: In India, the routine Active Management of Third-Stage of Labour
(AMTSL) with conventional intramuscular oxytocin, at the rural, resource-constrained areas …